MYC and cancer: Recently, we showed that TNKS1/2 inhibition cell-type dependently can block WNT/β-catenin and/or YAP signaling, and consequently MYC proto-oncogene bHLH transcription factor (MYC) signaling, resulting in attenuated cancer cell growth (7).